QSO-20-19-ESRD REVISED
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
The document is ready to print
Click below to print the document in a new window. When finished, you can return to this tab to continue.
Print PDF
[customised-link]
Clearpol's Opinion of this Guidance as of 03/30/2020
Clearpol Inc. does not make any guarantees regarding the accuracy of the opinions provided on our platform. Please use your own judgement.
Clearpol's AI Summary
The Centers for Medicare & Medicaid Services (CMS) issued a memo providing guidance for infection control and prevention of COVID-19 in dialysis facilities. The memo emphasizes the importance of monitoring the CDC website for updates and coordinating with local health departments. Dialysis facilities are advised to focus on infection control and prevention practices, including guidance related to 1135 waivers and Special Purpose Renal Dialysis Facilities (SPRDFs). Facilities should screen patients, staff, and visitors for symptoms of respiratory infection and potential exposure to COVID-19. Additionally, facilities should ensure appropriate cleaning and disinfection of environmental surfaces and medical equipment. CMS will not cite facilities for lacking certain supplies if shortages are outside their control, but they are expected to take action to mitigate resource shortages.
Summaries are generataed using AI. Check important information.